I have to make some quick decisions on two differe approaches to my disease. Quick backstory, i had surgery in September, removed nodes, was in the advjuvent setting, then got on the interferon/Yervoy clincial radomized to Interferon, disease came back in December. Put on Yervoy, it only slowed things down but hasn’t halted anything and now I’m on to another drug.
There is a possible slot at Moffit for me OR Vanderbilt is offering me a clincial Phase 1/11to take a combo drug that is a BRAF and MEK Inhibitor. I have a call into my doctor to discuss both optoins further but I was wondering if any of you had experience?